FRAT2 抗体 (AA 131-230) (Cy3)
Our Local Distributor
北京 101111
Quick Overview for FRAT2 抗体 (AA 131-230) (Cy3) (ABIN1702849)
抗原
See all FRAT2 抗体适用
宿主
克隆类型
标记
应用范围
-
-
抗原表位
- AA 131-230
-
交叉反应
- 小鼠
-
预测反应
- Human,Rat,Dog,Cow,Sheep
-
纯化方法
- Purified by Protein A.
-
免疫原
- KLH conjugated synthetic peptide derived from human FRAT2
-
亚型
- IgG
-
-
anti-Frequently Rearranged in Advanced T-Cell Lymphomas 2 (FRAT2) (AA 203-230), (C-Term) antibody
FRAT2 适用: 人 WB, IF, IHC (p) 宿主: 兔 Polyclonal RB31392 unconjugated
anti-Frequently Rearranged in Advanced T-Cell Lymphomas 2 (FRAT2) (AA 210-233), (C-Term) antibodyFRAT2 适用: 人 WB, IF, IHC (p), EIA 宿主: 兔 Polyclonal unconjugated
anti-Frequently Rearranged in Advanced T-Cell Lymphomas 2 (FRAT2) (C-Term) antibodyVerified FRAT2 适用: 人 WB, ELISA 宿主: 山羊 Polyclonal unconjugated
-
-
应用备注
-
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200 -
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
浓度
- 1 μg/μL
-
缓冲液
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
-
储存液
- ProClin
-
注意事项
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
储存条件
- -20 °C
-
储存方法
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
-
有效期
- 12 months
-
-
- FRAT2 (Frequently Rearranged in Advanced T-Cell Lymphomas 2 (FRAT2))
-
别名
- FRAT2
-
背景
-
Synonyms: Frequently rearranged in advanced T-cell lymphomas 2 antibodyGSK-3 binding protein FRAT2, FRAT2_HUMAN.
Background: FRAT1 and FRAT2 were originally characterized as proteins frequently rearranged in advanced T cell lymphoma, and they have since been identified as proto-oncogenes involved in tumorigenesis. These proteins share significant homology with the Xenopus glycogen synthase kinase-3 (xGSK-3) binding protein, which is designated GBP and is essential for the formation of the dorsal-ventral axis during embryonic development. Establishment of these embryonic axes is mediated by the Wnt intracellular signaling pathway. Wnt signaling is regulated in part by the activity of GSK-3, which phosphorylates and thereby facilitates the degradation of ?catenin. GBP binds to GSK-3 and inhibits this phosphorylation, resulting in the accumulation of ?catenin and the subsequent transcription of Wnt target genes. Like GBP, FRAT2 has been shown to bind xGSK-3, suggesting that FRAT1 and FRAT2 may be GSK-3 regulatory proteins.
-
基因ID
- 23401
抗原
-
